Latanoprost Elvim

Latanoprost, the active ingredient in Latanoprost Elvim, is a prostaglandin F2α analog presented as an ophthalmic solution for ocular administration. It is used to lower intra‑ocular pressure in patients with primary open‑angle glaucoma or ocular hypertension, helping to preserve visual function.

GNH USA supplies Latanoprost Elvim as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, clinics and research institutions worldwide under strict quality standards.

Latanoprost is a prostaglandin analog used to manage conditions characterized by elevated intra‑ocular pressure.

Primary open-angle glaucoma: reduces intra‑ocular pressure and slows disease progression. Ocular hypertension: lowers intra‑ocular pressure to prevent conversion to glaucoma.

Latanoprost may cause ocular and peri‑ocular reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Eyelash changes: increased length, thickness or darkness. - Iris pigmentation: gradual darkening of the iris. - Eye irritation: burning or stinging sensation. - Blurred vision: transient visual disturbance. - Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash or difficulty breathing. - Ocular inflammation: uveitis or iritis. - Paradoxical IOP increase: unexpected rise in intra‑ocular pressure. - Corneal edema: swelling of the cornea affecting clarity. - Vision loss: sudden decrease in visual acuity. - Ocular infection: signs of bacterial or fungal infection.

Before using Latanoprost Elvim, consider the following safety measures.

Monitor intra‑ocular pressure: assess response after initiation. Avoid use in active ocular infection: infection may worsen. Caution in patients with a history of uveitis: may exacerbate inflammation. Do not wear contact lenses during treatment: lenses can trap the solution. Assess for hypersensitivity: discontinue if allergic signs appear. Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Latanoprost Elvim can interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concurrent use with other prostaglandin analog eye drops: increased risk of ocular side effects. - Use before ocular surgery: may affect wound healing.

Moderate Interactions (Monitor Closely): - Combined with beta‑blocker eye drops: additive IOP‑lowering effect, monitor pressure. - Combined with carbonic anhydrase inhibitor eye drops: potential for excessive pressure reduction. - Systemic NSAIDs or corticosteroids: may alter prostaglandin pathways, watch for changes in efficacy. - Use with topical anesthetics: possible reduced drug absorption.